Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | CAN1012 |
Trade Name | |
Synonyms | CAN-1012|CAN 1012 |
Drug Descriptions |
CAN1012 is a selective TLR7 agonist, which potentially results in increased immune response, leading to antitumor activity (Journal for ImmunoTherapy of Cancer 2022;10). |
DrugClasses | TLR7 Agonist 11 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CAN1012 | CAN1012 | 0 | 1 |